|
(August 8, 2005) -- Although Ritalin has been used for four decades to treat
children with attention deficit hyperactivity disorder (ADHD), there are still
many unanswered questions about its impact on growth, a newly published review
concludes.
Researchers analyzed 29 studies that included information on
height variations among children taking
Ritalin or the stimulant Dexedrine for
ADHD. They wrote that higher quality studies showed there was a clear
association between use of the stimulants and height retardation.
This amounted to a height deficit of approximately 1
centimeter per year during the first one to three years of treatment.
Many of the studies they reviewed were of poor quality, they
write.
None of the studies adequately addressed the question of
whether the drugs have a permanent impact on height in some children, according
to the researchers.
"It would appear that most children achieve a satisfactory
adult height, but there may be an important subgroup whose growth is permanently
attenuated," pediatrician Sally Poulton, MD, and colleagues from The University
of Sydney write.
Poulton says that most parents of kids with ADHD are
either unaware of slight variations in height associated
with the use of Ritalin
or are unconcerned about it. Weight loss in the early days of treatment is a
more commonly reported finding.
"Parents should expect their children to lose some weight and
grow more slowly for a time after starting on stimulant medication, and this
should be monitored," she says. "And we need better studies to identify children
who may perhaps be at risk for having their (adult) height affected."
Nausea May Be Warning Sign
Two of the studies reviewed by Poulton and colleagues suggest
that children who experience nausea and vomiting as an early side effect of
Ritalin may be uniquely vulnerable to slow growth.
University of Iowa psychologist John R. Kramer, PhD, who led
one of the research teams, reports that this small subgroup of Ritalin users
ended up more than 2 inches shorter than other Ritalin users.
In his study, 97 males who were treated with Ritalin for an
average of three years between the ages of 4 and 12 were evaluated for late
adolescent and adult height. In general, no significant height differences were
seen between the Ritalin users and nonusers.
In cases where the Ritalin user had a brother who was close
to the same age and who did not take the drug, for example, the siblings had
similar adult heights.
But Ritalin users who experienced nausea and/or vomiting when
starting the drug were found to be a full 2.6 inches shorter as adults than
Ritalin users who did not experience stomach problems as a side effect of the
drug.
While the finding suggests that the early side effect of
treatment may be associated with a large reduction in adult height, Kramer
points out that only a small percentage of treated children experienced nausea
and vomiting.
"This finding needs to be replicated before any conclusions
can be made," he says. "But if a child does experience this problem after
starting on Ritalin, it may be prudent to reconsider treatment."
500% Increase in Use
Roughly 10 million Ritalin prescriptions are filled each year
in the U.S. for the treatment of children and adults with ADHD. Sales of
Ritalin
and chemically similar drugs increased by more than 500% in the 1990s.
University of Texas Medical Branch pediatrics professor Wayne
Snodgrass, MD, says Ritalin's potential impact on height is not high on the list
of potential concerns about the drug. Snodgrass is chairman of the committee on
drugs of the American Academy of Pediatrics.
"A much bigger issue is whether kids are being given a
correct diagnosis before being given stimulants," he says. "Medication
can be very useful for some children, but parents need to make sure that their
child has a good thorough evaluation before considering it."
SOURCES: Poulton, A., Archives of Disease in Childhood, July,
2005; vol. 90: pp. 801-806. Sally Poulton, MD, Western Clinical School,
University of Sidney, Australia. Wayne Snodgrass, MD, PhD, professor of
pediatrics, University of Texas Medical Branch at Galveston; chairman, committee
on drugs of the American Academy of Pediatrics. John R. Kramer, PhD, psychiatry
department, University of Iowa.
next: Are
ADHD Drugs Addictive
top .
send to friend .
adhd site
map
Reviewed: 01/2006
|